The Effects of Normobaric Hypoxia on Blood Glucose Levels.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to observe whether there is a change in blood glucose levels in response to a 2 hour oral glucose tolerance tests (OGTT) during acute normobaric hypoxia (short term low oxygen levels at normal ambient air pressure).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Altitude Glucose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Tricare Insurance Beneficiary (military insurance) receiving care at Nellis AFB
* 5 males with a BMI \< 25; 5 males with a BMI \> 25 at least 18 years of age (MOFH personnel and DoD beneficiaries).
* 5 females with a BMI \< 25; 5 females with a BMI \> 25 at least 18 years of age (MOFH personnel and DoD beneficiaries).

-5 males and/or females, at least 18 years of age, that are type 2 diabetics (MOFH personnel and DoD beneficiaries).

Exclusion Criteria

* History of abnormal fasting glucose.
* Pulmonary disease.
* Any medications that change glucose control to include systemic steroid and diabetic medications.
* History of claustrophobia.
* Pregnant or breast feeding.
* Non-English speaking.
* Physical inability to wear/use the ROBD2

* Pulmonary disease.
* History of claustrophobia.
* Pregnant or breast feeding.
* Non-English speaking.
* Physical inability to wear/use the ROBD2

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Travis Russell, M.D.

Role: PRINCIPAL_INVESTIGATOR

Mike O'Callaghan Federal Hospital/Nellis Air Force Base

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FWH20110021H

Identifier Type: -

Identifier Source: org_study_id